27 April 2026 : Clinical Research
Retrospective Study of Serum Vitamin D Levels and Metabolic-Associated Fatty Liver Disease in 222 Children and Adolescents Aged 6-18 Years With Obesity
Ceren Yapar GümüşDOI: 10.12659/MSM.952489
Med Sci Monit 2026; 32:e952489
Table 4 Comparison of clinical and laboratory variables between non-MAFLD obesity and MAFLD obesity groups.
| Obesity without MAFLD | Obesity with MAFLD | P | |||||
|---|---|---|---|---|---|---|---|
| n | Mean | SD | n | Mean | SD | ||
| Age | 87 | 12.97 | 3.13 | 135 | 13.62 | 2.85 | 0.109a |
| 25(OH)D, ng/mL | 56 | 15.93 | 5.90 | 92 | 16.64 | 9.38 | 0.782b |
| Weight SDS | 87 | 3.02 | 0.90 | 133 | 3.45 | 1.11 | c |
| Height SDS | 87 | 0.17 | 1.21 | 133 | 0.41 | 1.12 | 0.126a |
| BMI SDS | 87 | 2.86 | 0.54 | 133 | 3.06 | 0.63 | b |
| Serum glucose | 86 | 91.63 | 7.78 | 132 | 98.36 | 35.72 | 0.087a |
| Insulin | 85 | 25.60 | 13.94 | 132 | 33.74 | 22.42 | b |
| Hba1c | 77 | 5.39 | 0.23 | 126 | 5.66 | 1.01 | a |
| HOMA-IR | 87 | 5.72 | 3.45 | 135 | 7.91 | 5.84 | b |
| ALT | 85 | 20.43 | 10.77 | 131 | 36.06 | 32.99 | b |
| AST | 85 | 20.00 | 5.61 | 130 | 29.89 | 22.12 | b |
| LDL-C | 87 | 90.71 | 27.72 | 129 | 92.28 | 26.18 | 0.674a |
| HDL-C | 87 | 48.69 | 9.99 | 130 | 44.91 | 9.55 | a |
| Total cholesterol | 87 | 162.14 | 28.84 | 129 | 161.98 | 31.46 | 0.970a |
| Triglycerides | 87 | 117.77 | 43.09 | 127 | 131.22 | 53.22 | 0.052a |
| TSH | 84 | 3.04 | 1.96 | 132 | 3.08 | 1.63 | 0.878a |
| FT4 | 84 | 1.30 | 1.12 | 132 | 1.18 | 0.16 | 0.202a |
| MAFLD – metabolic-associated fatty liver disease; SD – standard deviation; SDS – standard deviation score; BMI – body mass index; HOMA-IR – homeostasis model assessment of insulin resistance; HbA1c – glycated hemoglobin; ALT – alanine aminotransferase; AST – aspartate aminotransferase; HDL-C – high-density lipoprotein cholesterol; LDL-C – low-density lipoprotein cholesterol; TSH – thyroid-stimulating hormone; FT4 – free thyroxine; 25(OH)D – 25-hydroxyvitamin D. a test; b Mann-Whitney U test; c Welch test. | |||||||






